# US 2026/0077092 A1 · Injectable collagen implants and compositions and related systems, and methods of preparation and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077092 A1
- Document ID: US20260077092A1
- Status: Published application
- Kind: A1
- Application number: 19/397,689
- Filed: 2025-11-21
- Published: 2026-03-19
- Earliest claimed: 2024-07-26
- Assignees: Miach Orthopaedics, Inc.
- Applicants: Miach Orthopaedics, Inc.
- Inventors: Stephen WOHLERT; Rita PAPARAZZO
- Web page: https://patentgrep.com/patent/US20260077092A1

## CPC

- A61L 26/0033: {Collagen}
- A61F 2/0805: {Implements for inserting tendons or ligaments}
- A61F 2/0811: {Fixation devices for tendons or ligaments}
- A61F 2/4618: {of cartilage}
- A61L 27/20: Polysaccharides
- A61L 27/24: Collagen
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/3616: {Blood, e.g. platelet-rich plasma}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61M 5/19: having more than one chamber
- A61F 2002/0823: {Modular anchors comprising a plurality of separate parts}
- A61F 2002/0882: {Anchor in or on top of a bone tunnel, i.e. a hole running through the entire bone}
- A61L 2400/06: Flowable or injectable implant compositions
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- A61L 2430/10: for reconstruction of tendons or ligaments
- A61L 2430/24: for joint reconstruction
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Described herein are collagen slurries and collagen implants suitable for injection into a repair site to repair a tissue, for example, an anterior cruciate ligament, rotator cuff tendon, and/or a meniscus. Further described are systems including collagen implants, methods of preparing collagen slurries and implants, and methods of use thereof.

## Claims

### Claim at position 1

1-43. (canceled)

### Claim 44

A collagen slurry implant composition, comprising:
at least one collagen;
a buffer,
at least one salt,
at least one electrolyte, and
at least one glycosaminoglycan.

### Claim 45 (depends on 44)

The composition of claim 44, wherein the at least one collagen is derived from a source tissue from any mammal species.

### Claim 46 (depends on 44)

The composition of claim 44, wherein the at least one collagen is derived from human, bovine, or porcine tissues, or combinations thereof.

### Claim 47 (depends on 44)

The composition of claim 44, wherein the at least one collagen is derived from a soft tissue.

### Claim 48 (depends on 44)

The composition of claim 44, wherein the at least one collagen comprises Type I, Type II, Type III, Type IV, Type V, Type X, or combinations thereof.

### Claim 49 (depends on 44)

The composition of claim 44, wherein the at least one collagen comprises fibrillar collagen, tropocollagen, atelocollagen, heterotrimeric collagen, or combinations thereof.

### Claim 50 (depends on 44)

The composition of claim 44, wherein the at least one collagen is in an amount of about 40 w/w % to about 70 w/w %.

### Claim 51 (depends on 44)

The composition of claim 44, wherein the at least one collagen is in an amount of greater than 400 mg/g, or about 400 mg/g to about 10,000 mg/g.

### Claim 52 (depends on 44)

The composition of claim 44, wherein the at least one collagen is free of crosslinks.

### Claim 53 (depends on 44)

The composition of claim 44, wherein the buffer is a zwitterionic buffer, or
wherein the buffer comprises 4-(2-hydroxethyl)-1-piperazineethanesulfonic acid (HEPES), tris(hydroxymethyl)aminomethane) (TRIS), (3-(N-morpholino)propanesulfonic acid) (MOPS), 3-[N-Tris(hydroxymethyl) methylamino]-2-hydroxypropanesulfonic acid (TAPSO), cacodylate SSC, succinic acid, glycine, sodium phosphate, sodium hydroxide, sodium chloride, magnesium chloride, acetic acid, thrombin buffer, L-ascorbic acid phosphate magnesium salt n-hydrate, MMP-1, MMP-2, MMP-3, MMP-9, RNAase/DNAase, elastase, papain, citrate, sodium citrate, phosphate, saline, or combinations thereof.

### Claim 54

(canceled)

### Claim 55 (depends on 44)

The composition of claim 44, wherein the buffer is in an amount of about 15 w/w % to about 30 w/w %.

### Claim 56 (depends on 44)

The composition of claim 44, wherein the salt comprises calcium, magnesium, or combinations thereof, optionally wherein the at least one salt is in an amount of about 2 w/w % to about 5 w/w %.

### Claim 57

(canceled)

### Claim 58 (depends on 44)

The composition of claim 44, wherein the electrolyte comprises chloride, nitrate, sulfate, silicate, phosphate, aluminate, sodium tetraborate, or combinations thereof,
Optionally, wherein the electrolyte is in an amount of about 5 w/w % to about 11 w/w %.

### Claim 59

(canceled)

### Claim 60

(canceled)

### Claim 61 (depends on 44)

The composition of claim 44, wherein the at least one glycosaminoglycan is in an amount of less than about 2 w/w %, or about 0.001 w/w % to less than about 2 w/w %.

### Claim 62 (depends on 44)

The composition of claim 44, wherein the at least one glycosaminoglycan is in an amount of greater than 100 μg/g, or greater than about 100 μg/g to about 8,000 μg/g.

### Claim 63 (depends on 44)

The composition of claim 44, further comprising a growth factor, peptide, proteinase inhibitor, collagenase inhibitor, zinc ions, retinol, vitamin, steroid, hormone, cytokine, clotting factor, angiogenic protein, antiangiogenic protein, anti-protease protein, bone morphogenic protein, osteoinductive factor, fibronectin, cementum attachment extract, ketanserin, interlenkin-1, human alpha thrombin, an anti-inflammatory, or combinations thereof,
optionally, wherein the anti-inflammatory comprises a non-steroidal anti-inflammatory drug (NSAID), acetaminophen, an opioid, a cannabinoid, salicylic acid, lidocaine, or combinations thereof, optionally wherein the NSAID comprises ibuprofen, naproxen, diclofenac, celecoxib, mefenamic acid, etoricoxib, indomethacin, or combinations thereof, and optionally, wherein the opioid comprises hydrocodone, oxycodone, morphine, oxymorphone, codeine, or combinations thereof.

### Claim 64 (depends on 63)

The composition of claim 63, wherein at least one of:
the anti-protease protein comprises alphalantitrypsin, the antiangiogenic protein comprises endostatin, angiostatin, or combinations thereof,
the growth factor comprises endothelial cell growth factor, epidermal growth factor, transforming growth factor-beta, insulin-like growth factor, platelet derived growth factor, periodontal ligament chemotactic factor, vascular endothelial growth factor, fibroblast growth factor, or combinations thereof,
the hormone comprise human growth hormone, animal growth hormones, or combinations thereof, or
the vitamin comprises vitamin A, vitamin B6, vitamin B9, vitamin B12, vitamin C, vitamin D, vitamin K, or combinations thereof.

### Claim 65

(canceled)

### Claim 66

(canceled)

### Claim 67

(canceled)

### Claim 68 (depends on 44)

The composition of claim 44, further comprising DNA in amount of less than 50,000 ng/g, or about 5 ng/g to less than about 50,000 ng/g.

### Claim 69 (depends on 44)

The composition of claim 44, further comprising a phospholipid and having a phospholipid count of less than 3,000 μM/g, or about 1 μM/g to less than about 3,000 μM/g.

### Claim 70 (depends on 44)

The composition of claim 44, further comprising pepsin in an amount of less than 12.5 mg/g, or about 0.1 mg/g to less than about 12.5 mg/g.

### Claim at position 29

71-90. (canceled)
